Carisoprodol Immediate Release | Carisoprodol Tablet Breastfeeding

American Academy of Pediatrics and other medical experts exclusively recommend to breastfeed the baby for first 6 months. Once you introduce baby to other foods it is recommended to breastfeed for at least first year of babys life. Taking medication while breastfeeding could be tricky as most drugs pass in breast milk. In this article we will evaluate Carisoprodol Immediate Release | Carisoprodol Tablet for its safety in breastfeeding.

What is Carisoprodol Immediate Release | Carisoprodol Tablet used for?


Carisoprodol tablets USP is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Limitation of Use Carisoprodol tablets USP should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration [see Dosage and Administration (2)]. Carisoprodol tablets USP is a muscle relaxant indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults (1) Limitation of use • Should only be used for acute treatment periods up to two or three weeks (1)

Is using Carisoprodol Immediate Release | Carisoprodol Tablet unsafe in breastfeeding? Can there be bad consequences for baby if I use it while breastfeeding?

Carisoprodol Immediate Release | Carisoprodol Tablet low risk for breastfeeding
Carisoprodol is the one and only active ingredient present in Carisoprodol Immediate Release | Carisoprodol Tablet. Carisoprodol in itself is a low risk drug for lactation so it is easy to understand that Carisoprodol Immediate Release | Carisoprodol Tablet also comes in category of Low Risk item while breastfeeding. Below is the summary of Carisoprodol in breastfeeding.

Carisoprodol Immediate Release | Carisoprodol Tablet Breastfeeding Analsys


Carisoprodol while Breastfeeding

Low Risk

CAS Number: 78-44-4

Skeletal muscle relaxant with sedative effects on the central nervous system. It is metabolized to meprobamate.Indicated on low back pain. It is excreted into breast milk in a clinically non-significant amount (Nordeng 2001, Bailey 2002, Briggs 2008) without problems being observed on infants whose mothers were receiving this medication, (Nordeng 2001), except for a mild sedation with higher maternal drug doses (Briggs 2008) .Plasma levels in the infant were undetectable (Briggs 2008). Carisoprodol use increases the risk of abuse and addictive behavior, intoxication and possible psychomotor impairment (Bailey 2002, EMA 2007) being such a reason to be withdrawn from the market in some countries. The European Medicines Agency (EMA) has recommended to withhold authorizations for marketing of medicines that contains Carisoprodol (EMA 2007, Reeves 2012, Bramases 2012). If administered during breastfeeding, it is advisable to use a minimum effective dose and monitor a possible sedation on the infant and an inadequate milk production (Sachs 2013).

Carisoprodol Immediate Release | Carisoprodol Tablet Breastfeeding Analsys - 2


Carisoprodol while Breastfeeding

CAS Number: 78-44-4

If carisoprodol is required by the mother, it is not necessarily a reason to discontinue breastfeeding. Slight sedation has occurred in a breastfed newborn infant who was exposed during pregnancy and lactation; sedation might be more pronounced in newborns who are exposed for the first time during nursing. Other agents may be preferred, especially while nursing a newborn or preterm infant, or when other drugs that can cause sedation are used simultaneously.


I already used Carisoprodol Immediate Release | Carisoprodol Tablet and meanwhile I breastfed my baby should I be concerned?

During whole lactation period you shall first discuss with your doctor and then together you shall decide whether you shall take that drug or not however if you have already taken Carisoprodol Immediate Release | Carisoprodol Tablet then you shall inform your doctor, But you should not be worried too much as Carisoprodol Immediate Release | Carisoprodol Tablet comes in category of low risk drug.


My health care provider has asked me to use Carisoprodol Immediate Release | Carisoprodol Tablet, what to do?

Though Carisoprodol Immediate Release | Carisoprodol Tablet dose not comes in category of safe drugs rather it comes in category of low risk but if your doctor is aware that you are breastfeeding your baby and has still recommended it then its advantages must be outweighing the risks.


If I am using Carisoprodol Immediate Release | Carisoprodol Tablet, will my baby need extra monitoring?

Not much


Who can I talk to if I have questions about usage of Carisoprodol Immediate Release | Carisoprodol Tablet in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week